Morgan Cheatham

Advisor at ReturnSafe

Morgan Cheatham is a Vice President at Bessemer Venture Partners, specializing in healthcare and life sciences with an emphasis on computational applications since 2017. In addition to this role, Morgan is a Co-Founder of Decoding Bio, a board member at the Coalition for Health AI, and a member of the NEJM AI Editorial Team. As an interim Chief Executive Officer and Board Director at FOLX Health, Morgan actively contributes to healthcare innovation. Morgan also serves as a Limited Partner at Silver Beech Capital Management and First Close Partners, focusing on intrinsic value-based investments and supporting underrepresented managers in venture capital. Recognized by Forbes as a member of the 30 Under 30 in Venture Capital in 2023, Morgan's earlier experience includes roles as an Investment Banking Analyst at Goldman Sachs and a Data Scientist at Kyruus. Morgan holds a Doctor of Medicine degree from The Warren Alpert Medical School of Brown University and a Bachelor of Science in Computational Decision Sciences from Brown University, complemented by a foundational education from Thomas Jefferson High School for Science and Technology.

Location

New York, United States

Links


Org chart

This person is not in the org chart


Teams


Offices

This person is not in any offices